FDA guidance proposes devices be deemed adulterated for refusing inspections
Regulatory NewsJoanne S. Eglovitch
ComplianceMedical DevicesNorth AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/PolicyRegulatory NewsJoanne S. EglovitchComplianceMedical DevicesNorth AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy